-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IGU/WMdPkyzYHDA3xljBUN7YfmDsLpqvPsHw+KVlS1zbGoiPSOE2dZKe9JldEPIM w6q/Dbnc92EvXQDcXH+oIA== 0001209191-10-039761.txt : 20100727 0001209191-10-039761.hdr.sgml : 20100727 20100727174611 ACCESSION NUMBER: 0001209191-10-039761 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100723 FILED AS OF DATE: 20100727 DATE AS OF CHANGE: 20100727 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDASSETS INC CENTRAL INDEX KEY: 0001254419 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 510391128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NORTH POINT CENTER EAST STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30022 BUSINESS PHONE: 6783232500 MAIL ADDRESS: STREET 1: 100 NORTH POINT CENTER EAST STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WESSON BRUCE F CENTRAL INDEX KEY: 0001058190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33881 FILM NUMBER: 10972498 MAIL ADDRESS: STREET 2: 1827 PACIFIC ST CITY: BROOKLYN STATE: NY ZIP: 11233 FORMER NAME: FORMER CONFORMED NAME: WESSON BRUCE T DATE OF NAME CHANGE: 19980319 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-07-23 0 0001254419 MEDASSETS INC MDAS 0001058190 WESSON BRUCE F C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 1 0 0 0 Common Stock 2010-07-23 4 S 0 6522 24.06 D 5522955 I See FN Common Stock 2010-07-26 4 S 0 43938 24.2422 D 5479017 I See FN Common Stock 2010-07-27 4 S 0 16460 24.0831 D 5462557 I See FN Common Stock 54783 D The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009 The shares were sold as follows: 1,147 by Galen Partners IV, L.P. ("Galen IV"), 91 by Galen Partners International IV, L.P. ("Galen International IV"), 1 by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 4,828 by Galen Partners III, L.P. ("Galen III"), 438 by Galen Partners International III, L.P. ("Galen International III") and 17 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds"). The shares are held as follows: 970,857 by Galen IV, 77,123 by Galen International IV, 1,352 by Employee Fund IV, 4,085,650 by Galen III, 370,268 by Galen International III and 17,705 by Employee Fund III. Claudius IV, L.L.C. ("Claudius IV") serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Claudius, L.L.C. ("Claudius") serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. The Reporting Person is a member of Claudius IV, a member of Claudius and the sole shareholder of Wesson Enterprises. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. The shares were sold as follows: 7,728 by Galen IV, 615 by Galen International IV, 10 by Employee Fund IV, 32,524 by Galen III, 2,948 by Galen International III and 113 by Employee Fund III. The shares were sold at prices between $24.06 and $24.50. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 963,129 by Galen IV, 76,508 by Galen International IV, 1,342 by Employee Fund IV, 4,053,126 by Galen III, 367,320 by Galen International III and 17,592 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. The shares were sold as follows: 2,895 by Galen IV, 230 by Galen International IV, 4 by Employee Fund IV, 12,185 by Galen III, 1,104 by Galen International III and 42 by Employee Fund III. The shares were sold at prices between $24.06 and $24.32. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 960,234 by Galen IV, 76,278 by Galen International IV, 1,338 by Employee Fund IV, 4,040,941 by Galen III, 366,216 by Galen International III and 17,550 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. /s/ Bruce F. Wesson 2010-07-27 -----END PRIVACY-ENHANCED MESSAGE-----